Home

Glenmark Pharmaceuticals Ltd PE Ratio

Image

Glenmark Pharmaceuticals Ltd

NSE: GLENMARK

PE

-

Last updated on: Mar 28, 2025

Key Highlights

  • The P/E Ratio of Glenmark Pharmaceuticals Ltd is 0 as of 28 Mar 25 .
  • The P/E Ratio of Glenmark Pharmaceuticals Ltd changed from 7.5 on March 2020 to 0 on March 2024 . This represents a CAGR of -100.00% over 5 years.

Historical P/E Ratio of Glenmark Pharmaceuticals Ltd

No data available

Company Fundamentals for Glenmark Pharmaceuticals Ltd

Image

Glenmark Pharmaceuticals Ltd

NSE: GLENMARK

Share Price

₹ -

Last updated on: Jan 01, 2025

Market Price of Glenmark Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Glenmark Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
28 Mar 20251540.05
27 Mar 20251520.75
26 Mar 20251464.1
25 Mar 20251480.2
24 Mar 20251493.1
21 Mar 20251511.45
20 Mar 20251478.15
19 Mar 20251486.55
18 Mar 20251457.85
17 Mar 20251430.95

SWOT Analysis Of Glenmark Pharmaceuticals Ltd

Strength

4

che

Weakness

2

che

Opportunity

1

che

Threats

1

che

BlinkX Score for Glenmark Pharmaceuticals Ltd

Asset Value vs Market Value of Glenmark Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Key Valuation Metric of Glenmark Pharmaceuticals Ltd

X

Historical Market Cap of Glenmark Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Glenmark Pharmaceuticals Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Glenmark Pharmaceuticals Ltd

No data available

* All values are in %

About Glenmark Pharmaceuticals Ltd

  • Glenmark Pharmaceuticals Ltd was incorporated in November 18th, 1977.
  • The Company is actively involved in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity).
  • It is engaged in the business of development, manufacture and marketing of pharmaceutical products both formulation and active pharmaceuticals ingredients to regulated and semi-regulated markets. The company has several molecules in various stages of pre-clinical and clinical development primarily focused in the areas of Oncology, Respiratory and Dermatology.
  • Its branded generics business has a significant presence in markets across emerging economies including India.
  • The company has 14 manufacturing facilities across US, India, Argentina, Czech Republic and Switzerland.

Glenmark Pharmaceuticals Ltd News Hub

Glenmark Pharmaceuticals Ltd spurts 2.5%, rises for fifth straight session

Glenmark Pharmaceuticals Ltd gained for a fifth straight session today. The stock is quoting at Rs 1

Read more

21 Aug 24

Glenmark Pharmaceuticals Ltd soars 4.33%, rises for third straight session

Glenmark Pharmaceuticals Ltd rose for a third straight session today. The stock is quoting at Rs 163

Read more

19 Aug 24

Glenmark Pharma gains after American subsidiary launches Olopatadine generic

The solution is the generic version of 'Pataday Twice Daily Relief', which is distributed by Alcon L

Read more

19 Aug 24

Glenmark launches Olopatadine Hydrochloride Ophthalmic Solution

Glenmark Therapeutics Inc., USA (Glenmark) has launched Olopatadine Hydrochloride Ophthalmic Solutio

Read more

19 Aug 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions